Frees M - Search Results

Year	Number of Results
2009	1
2014	1
2017	1
2019	1
2021	1
2024	2
2025	2

1

Rad21l1 cohesin subunit is dispensable for spermatogenesis but not oogenesis in zebrafish.

Blokhina YP, Frees MA, Nguyen A, Sharifi M, Chu DB, Bispo K, Olaya I, Draper BW, Burgess SM. Blokhina YP, et al. Among authors: frees ma. PLoS Genet. 2021 Jun 17;17(6):e1009127. doi: 10.1371/journal.pgen.1009127. eCollection 2021 Jun. PLoS Genet. 2021. PMID: 34138874 Free PMC article.

2

Outcomes of Corticosteroid Injection for Lacertus Syndrome.

Frees M, Ward CM. Frees M, et al. Hand (N Y). 2025 Apr 12:15589447251331103. doi: 10.1177/15589447251331103. Online ahead of print. Hand (N Y). 2025. PMID: 40219767 Free PMC article.

3

Predictors of leech therapy failure in revascularized and replanted digits.

Toshinskiy S, Frees M, Hillard C. Toshinskiy S, et al. Among authors: frees m. J Hand Microsurg. 2024 May 28;16(4):100080. doi: 10.1016/j.jham.2024.100080. eCollection 2024 Oct. J Hand Microsurg. 2024. PMID: 39234374 Free PMC article.

4

Sleeping Beauty Insertional Mutagenesis Reveals Important Genetic Drivers of Central Nervous System Embryonal Tumors.

Beckmann PJ, Larson JD, Larsson AT, Ostergaard JP, Wagner S, Rahrmann EP, Shamsan GA, Otto GM, Williams RL, Wang J, Lee C, Tschida BR, Das P, Dubuc AM, Moriarity BS, Picard D, Wu X, Rodriguez FJ, Rosemarie Q, Krebs RD, Molan AM, Demer AM, Frees MM, Rizzardi AE, Schmechel SC, Eberhart CG, Jenkins RB, Wechsler-Reya RJ, Odde DJ, Huang A, Taylor MD, Sarver AL, Largaespada DA. Beckmann PJ, et al. Among authors: frees mm. Cancer Res. 2019 Mar 1;79(5):905-917. doi: 10.1158/0008-5472.CAN-18-1261. Epub 2019 Jan 23. Cancer Res. 2019. PMID: 30674530 Free PMC article.

5

The current landscape of clinical exome and genome reanalysis in the U.S.

Frees M, Carter JN, Wheeler MT, Reuter C. Frees M, et al. J Genet Couns. 2025 Apr;34(2):e1968. doi: 10.1002/jgc4.1968. Epub 2024 Sep 16. J Genet Couns. 2025. PMID: 39285507

6

Prophylactic treatment of age-related macular degeneration report number 2: 810-nanometer laser to eyes with drusen: bilaterally eligible patients.

Friberg TR, Brennen PM, Freeman WR, Musch DC; PTAMD Study Group. Friberg TR, et al. Ophthalmic Surg Lasers Imaging. 2009 Nov-Dec;40(6):530-8. doi: 10.3928/15428877-20091030-01. Ophthalmic Surg Lasers Imaging. 2009. PMID: 19928717 Clinical Trial.

7

Treatment of resistant metastatic melanoma using sequential epigenetic therapy (decitabine and panobinostat) combined with chemotherapy (temozolomide).

Xia C, Leon-Ferre R, Laux D, Deutsch J, Smith BJ, Frees M, Milhem M. Xia C, et al. Among authors: frees m. Cancer Chemother Pharmacol. 2014 Oct;74(4):691-7. doi: 10.1007/s00280-014-2501-1. Epub 2014 Jul 26. Cancer Chemother Pharmacol. 2014. PMID: 25062770 Free PMC article. Clinical Trial.

8

Targeting epigenetics for treatment of BRAF mutated metastatic melanoma with decitabine in combination with vemurafenib: A phase lb study.

Zakharia Y, Monga V, Swami U, Bossler AD, Freesmeier M, Frees M, Khan M, Frydenlund N, Srikantha R, Vanneste M, Henry M, Milhem M. Zakharia Y, et al. Among authors: frees m. Oncotarget. 2017 Sep 26;8(51):89182-89193. doi: 10.18632/oncotarget.21269. eCollection 2017 Oct 24. Oncotarget. 2017. PMID: 29179510 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Results by year